Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function
- PMID: 29911570
- PMCID: PMC6025959
- DOI: 10.7554/eLife.30938
Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function
Abstract
Energy metabolism is essential for T cell function. However, how persistent antigenic stimulation affects T cell metabolism is unknown. Here, we report that long-term in vivo antigenic exposure induced a specific deficit in numerous metabolic enzymes. Accordingly, T cells exhibited low basal glycolytic flux and limited respiratory capacity. Strikingly, blockade of inhibitory receptor PD-1 stimulated the production of IFNγ in chronic T cells, but failed to shift their metabolism towards aerobic glycolysis, as observed in effector T cells. Instead, chronic T cells appeared to rely on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO) to produce ATP for IFNγ synthesis. Check-point blockade, however, increased mitochondrial production of superoxide and reduced viability and effector function. Thus, in the absence of a glycolytic switch, PD-1-mediated inhibition appears essential for limiting oxidative metabolism linked to effector function in chronic T cells, thereby promoting survival and functional fitness.
Keywords: PD-1; T lymphocytes; immunology; inflammation; metabolism; mouse.
© 2018, Bettonville et al.
Conflict of interest statement
MB, Sd, KW, PP, JZ, SB, PS, MB No competing interests declared
Figures








Similar articles
-
PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes.J Immunother Cancer. 2019 Jun 13;7(1):151. doi: 10.1186/s40425-019-0628-7. J Immunother Cancer. 2019. PMID: 31196176 Free PMC article.
-
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.Breast Cancer Res. 2016 May 11;18(1):50. doi: 10.1186/s13058-016-0708-2. Breast Cancer Res. 2016. PMID: 27169467 Free PMC article.
-
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.Clin Cancer Res. 2017 Jan 15;23(2):454-465. doi: 10.1158/1078-0432.CCR-16-1163. Epub 2016 Jul 28. Clin Cancer Res. 2017. PMID: 27470968 Free PMC article.
-
Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C.Cells. 2021 Mar 3;10(3):538. doi: 10.3390/cells10030538. Cells. 2021. PMID: 33802622 Free PMC article. Review.
-
T cell checkpoint regulators in the heart.Cardiovasc Res. 2019 Apr 15;115(5):869-877. doi: 10.1093/cvr/cvz025. Cardiovasc Res. 2019. PMID: 30721928 Free PMC article. Review.
Cited by
-
CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?Clin Cancer Res. 2021 Nov 1;27(21):5742-5752. doi: 10.1158/1078-0432.CCR-21-0206. Epub 2021 Jun 14. Clin Cancer Res. 2021. PMID: 34127507 Free PMC article. Review.
-
Regulation of CD8+ T memory and exhaustion by the mTOR signals.Cell Mol Immunol. 2023 Sep;20(9):1023-1039. doi: 10.1038/s41423-023-01064-3. Epub 2023 Aug 15. Cell Mol Immunol. 2023. PMID: 37582972 Free PMC article. Review.
-
Expression of the monocarboxylate transporter MCT1 is required for virus-specific mouse CD8+ T cell memory development.Proc Natl Acad Sci U S A. 2024 Mar 26;121(13):e2306763121. doi: 10.1073/pnas.2306763121. Epub 2024 Mar 18. Proc Natl Acad Sci U S A. 2024. PMID: 38498711 Free PMC article.
-
BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.PLoS One. 2022 May 4;17(5):e0266980. doi: 10.1371/journal.pone.0266980. eCollection 2022. PLoS One. 2022. PMID: 35507536 Free PMC article.
-
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates.Front Oncol. 2023 Feb 27;13:1124039. doi: 10.3389/fonc.2023.1124039. eCollection 2023. Front Oncol. 2023. PMID: 36923424 Free PMC article.
References
-
- Bengsch B, Johnson AL, Kurachi M, Odorizzi PM, Pauken KE, Attanasio J, Stelekati E, McLane LM, Paley MA, Delgoffe GM, Wherry EJ. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity. 2016;45:358–373. doi: 10.1016/j.immuni.2016.07.008. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources